Small cationic amphiphilic α-helical peptides are emerging as agents for the treatment of cancer and infection, but they are costly and display unfavourable pharmacokinetics. Helical coordination complexes may offer a three-dimensional scaffold for the synthesis of mimetic architectures. However, the high symmetry and modest functionality of current systems offer little scope to tailor the structure to interact with specific biomolecular targets, or to create libraries for phenotypic screens. Here, we report the highly stereoselective asymmetric self-assembly of very stable, functionalized metallohelices. Their anti-parallel head-to-head-to-tail "triplex" strand arrangement creates an amphipathic functional topology akin to that of the active sub-units of, for example, host-defence peptides and p53. The metallohelices display high, structure-dependent toxicity to the human colon carcinoma cell-line HCT116 p53++, causing dramatic changes in the cell cycle without DNA damage. They have lower toxicity to human breast adenocarcinoma cells (MDA-MB-468) and, most remarkably, they show no significant toxicity to the bacteria methicillin-resistant Staphylococcus aureus and Escherichia coli.
|Number of pages||7|
|Early online date||3 Aug 2014|
|Publication status||Published - 1 Sep 2014|
FingerprintDive into the research topics of 'Asymmetric triplex metallohelices with high and selective activity against cancer cells'. Together they form a unique fingerprint.
- Department of Pharmacy - Associate Dean of Research Innovation and Knowledge Exchange
- School of Applied Sciences
- Pharmacology and Therapeutics Centre - Director
- Cellular and Molecular Models of Disease Centre - Associate Membership
- Centre for Biomimetic Societal Futures